Table 2.
Guideline |
Checklist |
Cobb et al.13 |
Amditis and Smith10 |
Vu et al.12 |
Detterline et al.11 |
|
Objective |
Common Design |
|||||
Study design appropriate to objective? | Prevalence | Cross-sectional | NA | NA | NA | NA |
Prognosis | Cohort | NA | 0 | 0 | 0 | |
Treatment | Controlled trial | 0 | NA | NA | NA | |
Cause | Cohort, case-control, cross-sectional | NA | NA | NA | NA | |
Study sample representative? | Source of sample | 0 | + | + | + | |
Sampling method | 0 | + | + | + | ||
Sample size | 0 | + | ++ | ++ | ||
Entry criteria/exclusions | 0 | 0 | 0 | 0 | ||
Nonrespondents | 0 | 0 | 0 | 0 | ||
Control group acceptable? | Definition of controls | 0 | 0 | 0 | 0 | |
Source of controls | 0 | 0 | 0 | 0 | ||
Matching/randomization | 0 | + | + | + | ||
Comparable characteristics | 0 | 0 | 0 | 0 | ||
Quality of measurements and outcomes? | Validity | 0 | 0 | 0 | 0 | |
Reproducibility | + | + | + | + | ||
Blindness | NA | NA | NA | NA | ||
Quality control | 0 | 0 | 0 | 0 | ||
Completeness? | Compliance | 0 | 0 | 0 | 0 | |
Dropouts | 0 | 0 | 0 | 0 | ||
Deaths | NA | NA | NA | NA | ||
Missing data | + | + | + | + | ||
Distorting influences? | Extraneous treatments | + | 0 | + | 0 | |
Contamination | NA | NA | NA | NA | ||
Changes over time | 0 | 0 | 0 | 0 | ||
Confounding factors | + | 0 | + | + | ||
Distortion reduced by analysis | 0 | 0 | + | 0 | ||
Summary questions | Bias: Are the results erroneously biased in a certain direction? | No | No | Yes | Yes | |
Confounding: Are there any serious confounding or other distorting influences? | Yes | Yes | Yes | Yes | ||
Chance: Is it likely that the results occurred by chance? | No | Yes | No | No |
++: major problem; +: minor problem; 0: no problem; NA: not applicable.